Infliximab (Inflectra)
Clinical Biochemistry
Sample and container requirements
Serum SST (preferred) EDTA Plasma Lithium Heparin Plasma (paediatrics only) Citrate Plasma
Minimum volume required
300 μL serum/plasma
Special requirements
If transport is going to be delayed by > 5 days, freeze at -20°C and send by first class post at a later date.
Patient preparation
Trough sample preferred.
Sample viability
Turnaround time
21 days
Reference range
Please refer to report for reference ranges.
Clinical guidance
Please follow the link below to the referral laboratory website for more information: https://synlab.co.uk/test-database/infliximab-remicade-remsima-inflectra/
Notes
Sent to Synnovis (St Thomas' Hospital)
Images to go here
This information was last updated on 19 August 2026